{"transactions":[{"id":4630228,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-05T20:30:02.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":759,"derivative":{"exercise_price":31.59,"exercise_date":"2026-10-01","expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":759},"source":{"system":"sec-edgar","filing":"0001193125-26-414218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312526414218/ownership.xml","form_type":"4"}},{"id":714487,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-06T20:30:27.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":627,"derivative":{"exercise_price":38.48,"exercise_date":"2026-07-01","expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":627},"source":{"system":"sec-edgar","filing":"0001193125-26-296249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526296249/ownership.xml","form_type":"4"}},{"id":741217,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:25.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526267663/ownership.xml","form_type":"4"}},{"id":770366,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:13:27.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":22000,"derivative":{"exercise_price":4.52,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001598502-26-000002","document":"wk-form4_1779308004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000159850226000002/wk-form4_1779308004.xml","form_type":"4"}},{"id":770365,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:13:27.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001598502-26-000002","document":"wk-form4_1779308004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000159850226000002/wk-form4_1779308004.xml","form_type":"4"}},{"id":770364,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:13:27.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001598502-26-000002","document":"wk-form4_1779308004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000159850226000002/wk-form4_1779308004.xml","form_type":"4"}},{"id":770363,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:13:27.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":14750,"source":{"system":"sec-edgar","filing":"0001598502-26-000002","document":"wk-form4_1779308004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000159850226000002/wk-form4_1779308004.xml","form_type":"4"}},{"id":815660,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:01:03.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":686,"derivative":{"exercise_price":35.24,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":686},"source":{"system":"sec-edgar","filing":"0001193125-26-142082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526142082/ownership.xml","form_type":"4"}},{"id":950034,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:01:03.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":643,"derivative":{"exercise_price":34.74,"exercise_date":"2026-01-01","expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":643},"source":{"system":"sec-edgar","filing":"0001193125-26-002367","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526002367/ownership.xml","form_type":"4"}},{"id":1024066,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T20:16:22.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":1642,"derivative":{"exercise_price":14.13,"exercise_date":"2025-10-01","expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":1642},"source":{"system":"sec-edgar","filing":"0001193125-25-230215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312525230215/ownership.xml","form_type":"4"}},{"id":1094238,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:15:43.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":3314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3314,"derivative":{"exercise_price":7.22,"exercise_date":"2025-07-01","expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":3314},"source":{"system":"sec-edgar","filing":"0000950170-25-092976","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025092976/ownership.xml","form_type":"4"}},{"id":1120896,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:25:51.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025082374/ownership.xml","form_type":"4"}},{"id":1137737,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T20:02:23.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":22000,"derivative":{"exercise_price":1.49,"expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001125345-25-000080","document":"wk-form4_1747944136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000080/wk-form4_1747944136.xml","form_type":"4"}},{"id":1137736,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T20:02:23.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001125345-25-000080","document":"wk-form4_1747944136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000080/wk-form4_1747944136.xml","form_type":"4"}},{"id":1137735,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T20:02:23.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001125345-25-000080","document":"wk-form4_1747944136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000080/wk-form4_1747944136.xml","form_type":"4"}},{"id":1137734,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:02:23.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":true,"shares":6500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001125345-25-000080","document":"wk-form4_1747944136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000080/wk-form4_1747944136.xml","form_type":"4"}},{"id":1178799,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T20:05:21.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3788,"derivative":{"exercise_price":5.79,"exercise_date":"2025-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0000950170-25-050374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025050374/ownership.xml","form_type":"4"}},{"id":1313449,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T21:21:26.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":2785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2785,"derivative":{"exercise_price":7.8,"exercise_date":"2025-01-01","expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":2785},"source":{"system":"sec-edgar","filing":"0000950170-25-001210","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025001210/ownership.xml","form_type":"4"}},{"id":1393704,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T20:14:19.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":2034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2034,"derivative":{"exercise_price":10.75,"exercise_date":"2024-10-01","expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":2034},"source":{"system":"sec-edgar","filing":"0000950170-24-111468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024111468/ownership.xml","form_type":"4"}},{"id":1462091,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-02T20:31:16.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2462,"derivative":{"exercise_price":8.94,"exercise_date":"2024-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0000950170-24-080555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024080555/ownership.xml","form_type":"4"}},{"id":1480217,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:14:15.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073234","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024073234/ownership.xml","form_type":"4"}},{"id":1504085,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T21:17:13.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":16500,"derivative":{"exercise_price":4.26,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001125345-24-000130","document":"wk-form4_1716499019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000130/wk-form4_1716499019.xml","form_type":"4"}},{"id":1504084,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-23T21:17:13.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":6500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001125345-24-000130","document":"wk-form4_1716499019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000130/wk-form4_1716499019.xml","form_type":"4"}},{"id":1505889,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-22T20:32:56.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001125345-24-000102","document":"wk-form4_1716409951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000102/wk-form4_1716409951.xml","form_type":"4"}},{"id":1505888,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T20:32:56.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001125345-24-000102","document":"wk-form4_1716409951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000102/wk-form4_1716409951.xml","form_type":"4"}},{"id":1552709,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-02T22:21:13.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":3213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3213,"derivative":{"exercise_price":6.9,"exercise_date":"2024-04-01","expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":3213},"source":{"system":"sec-edgar","filing":"0000950170-24-040496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024040496/ownership.xml","form_type":"4"}},{"id":1686969,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T21:24:05.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":3298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3298,"derivative":{"exercise_price":6.24,"exercise_date":"2024-01-02","expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":3298},"source":{"system":"sec-edgar","filing":"0000950170-24-001886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024001886/ownership.xml","form_type":"4"}},{"id":1766581,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-03T20:51:38.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":2345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2345,"derivative":{"exercise_price":9.55,"exercise_date":"2023-10-02","expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":2345},"source":{"system":"sec-edgar","filing":"0000950170-23-051604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017023051604/ownership.xml","form_type":"4"}},{"id":1835191,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T20:53:33.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":1884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":1884,"derivative":{"exercise_price":11.96,"exercise_date":"2023-07-03","expiration_date":"2033-07-03","underlying":"Common Stock","underlying_shares":1884},"source":{"system":"sec-edgar","filing":"0000950170-23-031704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017023031704/ownership.xml","form_type":"4"}},{"id":1861770,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:47:42.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":36700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":36700,"derivative":{"exercise_price":11.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":36700},"source":{"system":"sec-edgar","filing":"0000899243-23-014900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924323014900/doc4.xml","form_type":"4"}},{"id":1870565,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:59:21.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier."}],"balance_after":4500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001125345-23-000100","document":"wk-form4_1685739551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000100/wk-form4_1685739551.xml","form_type":"4"}},{"id":1870564,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:59:21.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":19000,"derivative":{"exercise_price":4.67,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001125345-23-000100","document":"wk-form4_1685739551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000100/wk-form4_1685739551.xml","form_type":"4"}},{"id":1926792,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T20:16:12.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":2053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2053,"derivative":{"exercise_price":10.75,"exercise_date":"2023-04-03","expiration_date":"2033-04-03","underlying":"Common Stock","underlying_shares":2053},"source":{"system":"sec-edgar","filing":"0000899243-23-010395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924323010395/doc4.xml","form_type":"4"}},{"id":2065735,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T21:30:24.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1862,"price":7.1854,"value":13379.2148,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":1862,"derivative":{"exercise_price":11.07,"exercise_date":"2023-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":1862},"source":{"system":"sec-edgar","filing":"0000899243-23-000615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924323000615/doc4.xml","form_type":"4"}},{"id":2143638,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:30:12.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":1474,"price":9.076,"value":13378.024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":1474,"derivative":{"exercise_price":14.33,"exercise_date":"2022-10-03","expiration_date":"2032-10-03","underlying":"Common Stock","underlying_shares":1474},"source":{"system":"sec-edgar","filing":"0000899243-22-032661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924322032661/doc4.xml","form_type":"4"}},{"id":2213934,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-05T17:52:24.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":2279,"price":5.8706,"value":13379.0974,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2279,"derivative":{"exercise_price":9.39,"exercise_date":"2022-07-01","expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":2279},"source":{"system":"sec-edgar","filing":"0000899243-22-024930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924322024930/doc4.xml","form_type":"4"}},{"id":2237259,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:13:22.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":30700,"derivative":{"exercise_price":4.59,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0000899243-22-021648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924322021648/doc4.xml","form_type":"4"}},{"id":2260426,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T01:06:25.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":20640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":20640,"derivative":{"exercise_price":3.9,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":20640},"source":{"system":"sec-edgar","filing":"0001125345-22-000063","document":"wf-form4_165335437160079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534522000063/wf-form4_165335437160079.xml","form_type":"4"}},{"id":2260425,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T01:06:25.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":18000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001125345-22-000063","document":"wf-form4_165335437160079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534522000063/wf-form4_165335437160079.xml","form_type":"4"}},{"id":2303483,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-05T20:06:05.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":2753,"price":4.86,"value":13379.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2753,"derivative":{"exercise_price":7.92,"exercise_date":"2022-04-01","expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":2753},"source":{"system":"sec-edgar","filing":"0000899243-22-013710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924322013710/doc4.xml","form_type":"4"}},{"id":2447358,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T02:25:04.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":2329,"price":5.153,"value":12001.337,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":2329,"derivative":{"exercise_price":8.7,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":2329},"source":{"system":"sec-edgar","filing":"0000899243-22-000693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924322000693/doc4.xml","form_type":"4"}},{"id":2547968,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T23:45:48.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":2385,"price":5.0317,"value":12000.6045,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":2385,"derivative":{"exercise_price":8.54,"expiration_date":"2031-10-01","underlying":"Common Stock","underlying_shares":2385},"source":{"system":"sec-edgar","filing":"0000899243-21-039329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924321039329/doc4.xml","form_type":"4"}},{"id":2640475,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T23:05:40.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":2513,"price":4.7754,"value":12000.5802,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":2513,"derivative":{"exercise_price":8.02,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":2513},"source":{"system":"sec-edgar","filing":"0000899243-21-027625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924321027625/doc4.xml","form_type":"4"}},{"id":2710609,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T01:18:01.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":28.88,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001125345-21-000071","document":"wf-form4_162130066448767.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534521000071/wf-form4_162130066448767.xml","form_type":"4"}},{"id":2756737,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-06T01:09:04.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":2121,"price":5.6577,"value":11999.9817,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":2121,"derivative":{"exercise_price":9.08,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":2121},"source":{"system":"sec-edgar","filing":"0000899243-21-014969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924321014969/doc4.xml","form_type":"4"}},{"id":2788732,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T23:05:56.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a three year period."}],"balance_after":60000,"derivative":{"exercise_price":8.45,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-011698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924321011698/doc4.xml","form_type":"4"}},{"id":2914632,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T02:47:31.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":1575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":1575,"derivative":{"exercise_price":7.6191,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":1575},"source":{"system":"sec-edgar","filing":"0000899243-21-000792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000089924321000792/doc4.xml","form_type":"4"}},{"id":3015384,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T21:30:09.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":8878,"price":1.3518,"value":12001.2804,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":8878,"derivative":{"exercise_price":2.26,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":8878},"source":{"system":"sec-edgar","filing":"0001209191-20-053277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919120053277/doc4.xml","form_type":"4"}},{"id":3088158,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T20:27:01.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":38487,"price":0.3118,"value":12000.2466,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":38487,"derivative":{"exercise_price":0.47,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":38487},"source":{"system":"sec-edgar","filing":"0001209191-20-041016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919120041016/doc4.xml","form_type":"4"}},{"id":3102400,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:47:07.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.74,"expiration_date":"2029-07-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-20-013673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013673/rdgdoc.xml","form_type":"4"}},{"id":3102399,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:47:07.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":8.99,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-20-013673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013673/rdgdoc.xml","form_type":"4"}},{"id":3102398,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:47:07.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.95,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-20-013673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013673/rdgdoc.xml","form_type":"4"}},{"id":3102397,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:47:07.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.89,"expiration_date":"2026-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-20-013673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013673/rdgdoc.xml","form_type":"4"}},{"id":3102396,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:47:07.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.72,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-20-013673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013673/rdgdoc.xml","form_type":"4"}},{"id":3102395,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:47:07.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.47,"expiration_date":"2024-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-20-013673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013673/rdgdoc.xml","form_type":"4"}},{"id":3102394,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:47:07.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect.  Each of these options is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.5,"expiration_date":"2024-01-28","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-20-013673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013673/rdgdoc.xml","form_type":"4"}},{"id":3112909,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T20:24:16.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":14331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":14331,"derivative":{"exercise_price":0.63,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":14331},"source":{"system":"sec-edgar","filing":"0001209191-20-035926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919120035926/doc4.xml","form_type":"4"}},{"id":3147538,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-15T20:36:23.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":24.97,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001125345-20-000088","document":"wf-form4_158957496520267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534520000088/wf-form4_158957496520267.xml","form_type":"4"}},{"id":3179481,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-08T21:41:12.000Z","date":"2020-04-06","kind":"grant","acquired":true,"shares":54422,"price":0.2205,"value":12000.051,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":54422,"derivative":{"exercise_price":0.3495,"expiration_date":"2030-04-06","underlying":"Common Stock","underlying_shares":54422},"source":{"system":"sec-edgar","filing":"0001209191-20-023945","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919120023945/doc4.xml","form_type":"4"}},{"id":3317451,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T21:45:18.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":26480,"price":0.4532,"value":12000.736,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":26480,"derivative":{"exercise_price":0.72,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":26480},"source":{"system":"sec-edgar","filing":"0001209191-20-001889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919120001889/doc4.xml","form_type":"4"}},{"id":3397941,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T20:41:14.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":13646,"price":0.8794,"value":12000.2924,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":13646,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":13646},"source":{"system":"sec-edgar","filing":"0001209191-19-052261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919119052261/doc4.xml","form_type":"4"}},{"id":3462164,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-07-15T09:01:52.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options become exercisable in 12 monthly installments, commencing one month from the grant date."}],"balance_after":25000,"derivative":{"exercise_price":5.74,"expiration_date":"2029-07-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-19-003933","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019003933/primarydocument.xml","form_type":"4"}},{"id":3467313,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T20:06:24.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":6199,"price":1.7745,"value":11000.1255,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":6199,"derivative":{"exercise_price":2.41,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":6199},"source":{"system":"sec-edgar","filing":"0001209191-19-041043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919119041043/doc4.xml","form_type":"4"}},{"id":3482160,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T20:17:05.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":14331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) June 18, 2020, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":14331,"derivative":{"exercise_price":2.7,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":14331},"source":{"system":"sec-edgar","filing":"0001209191-19-038220","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919119038220/doc4.xml","form_type":"4"}},{"id":3518825,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-20T21:50:10.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":4616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":4616,"derivative":{"exercise_price":18,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":4616},"source":{"system":"sec-edgar","filing":"0001125345-19-000078","document":"wf-form4_155838899552570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534519000078/wf-form4_155838899552570.xml","form_type":"4"}},{"id":3518824,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-20T21:50:10.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":18,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-19-000078","document":"wf-form4_155838899552570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534519000078/wf-form4_155838899552570.xml","form_type":"4"}},{"id":3563689,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-03T20:26:40.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":4047,"price":2.7185,"value":11001.7695,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4047,"derivative":{"exercise_price":4.4,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":4047},"source":{"system":"sec-edgar","filing":"0001209191-19-023125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919119023125/doc4.xml","form_type":"4"}},{"id":3703087,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:54:28.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":4073,"price":2.7,"value":10997.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4073,"derivative":{"exercise_price":4.47,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":4073},"source":{"system":"sec-edgar","filing":"0001209191-19-002042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919119002042/doc4.xml","form_type":"4"}},{"id":3797815,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T21:14:48.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":1769,"price":6.22,"value":11003.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":1769,"derivative":{"exercise_price":10.37,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":1769},"source":{"system":"sec-edgar","filing":"0001209191-18-053965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919118053965/doc4.xml","form_type":"4"}},{"id":3807053,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-26T22:43:21.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":1261,"price":8.72,"value":10995.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":1261,"derivative":{"exercise_price":14.57,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":1261},"source":{"system":"sec-edgar","filing":"0001209191-18-052360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000120919118052360/doc4.xml","form_type":"4"}},{"id":3894762,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-06-14T14:37:33.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable immediately on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":8.99,"exercise_date":"2018-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-18-002995","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218018002995/primarydocument.xml","form_type":"4"}},{"id":3924233,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-21T20:54:50.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":21.34,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-18-000074","document":"wf-form4_152693607650703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534518000074/wf-form4_152693607650703.xml","form_type":"4"}},{"id":4281605,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2017-06-15T15:09:28.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable immediately, on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":6.95,"exercise_date":"2017-06-14","expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-17-002271","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218017002271/primarydocument.xml","form_type":"4"}},{"id":4310243,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-22T23:02:01.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":19.57,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-17-000077","document":"wf-form4_149549410690686.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000077/wf-form4_149549410690686.xml","form_type":"4"}},{"id":4481995,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-25T22:58:35.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest 1/12th of the shares monthly, beginning on the first monthly anniversary of the grant date and will become fully exercisable 1 year from the date of grant (1/24/18)."}],"balance_after":20000,"derivative":{"exercise_price":18.52,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001125345-17-000014","document":"wf-form4_148538510247396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000014/wf-form4_148538510247396.xml","form_type":"4"}}]}